TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34330219

Group type: EXPERIMENTAL
Intervention: VieScope
Number of subjects: 35

Group type: COMPARATOR
Intervention: GlideScope
Number of subjects: 35

Group type: COMPARATOR
Intervention: MAC
Number of subjects: 35
Study: 32481487

Group type: EXPERIMENTAL
Intervention: Mediterranean diet group (MDG)
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Mediterranean lifestyle group (MLG)
Number of subjects: 187

Group type: COMPARATOR
Intervention: Standard care group (SCG)
Number of subjects: 187
Study: 36208720

Group type: EXPERIMENTAL
Intervention: Ozanimod 0.92 mg daily for 12 weeks during induction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ozanimod maintenance therapy for 52 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo for 12 weeks during induction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo maintenance therapy for 52 weeks
Number of subjects: 0
Study: 33039291

Group type: EXPERIMENTAL
Intervention: Subcutaneous immunoglobulin (IgPro20) 0.2 g/kg bodyweight
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Subcutaneous immunoglobulin (IgPro20) 0.4 g/kg bodyweight
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33852121

Group type: COMPARATOR
Intervention: Capecitabine and Lapatinib
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Capecitabine, Lapatinib, and Cituxumumab
Number of subjects: 68
Study: 35761129

Group type: EXPERIMENTAL
Intervention: Survivorship care planning (SCP) intervention (one-session with written SCP and follow-up telephone call)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 89
Study: 34512358

Group type: EXPERIMENTAL
Intervention: Orlistat
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ezetimibe
Number of subjects: 0
Study: 35164816

Group type: EXPERIMENTAL
Intervention: Personalized home-based physical activity program (PA)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 80